The past, present and future of anti-malarial medicines

Malar J. 2019 Mar 22;18(1):93. doi: 10.1186/s12936-019-2724-z.

Abstract

Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide. Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact. Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead. New drugs are needed, particularly those with new mechanisms of action. Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine. A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated. Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.

Keywords: Drug development; Drug discovery; Malaria; Mechanism of action; Plasmodium.

Publication types

  • Review

MeSH terms

  • Antimalarials / pharmacology*
  • Humans
  • Malaria / drug therapy*

Substances

  • Antimalarials